---
schema_version: "secwatch.filing_event.v1"
accession: "0001826667-25-000129"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2025-08-29T23:59:59+00:00"
generated_at: "2026-05-17T09:17:41.733498+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# TriSalus Life Sciences raises CFO base salary to $550K, grants performance-based stock options

## Summary
- CFO David Patience's annual base salary increased from $450K to $550K, effective immediately.
- Compensation Committee approved stock options for 249,899 shares at $5.11 per share.
- Options vest upon company achieving ≥$75M revenue in any 12 consecutive months by Dec 31, 2027.

## SEC filing metadata
- accession: 0001826667-25-000129
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2025-08-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000182666725000129/0001826667-25-000129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000182666725000129/tlsi-20250825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001826667-25-000129
- JSON: https://secwatch.observer/filing/0001826667-25-000129.json
- Plain text: https://secwatch.observer/filing/0001826667-25-000129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.